CR Intrinsic Investors’s PROLOR Biotech, Inc. Common Stock PBTH Stock Holding History

CR Intrinsic Investors’s Portfolio PBTH Stock Details PBTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-50,000	Closed	-$315K	–	472
2013 Q2	$315K	Buy	+50,000	New	+$299K	0.01%	324

Other funds holding PBTH

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

CR Intrinsic Investors's PBTH Position: Q3 2013 in Review

CR Intrinsic Investors sold out of PROLOR Biotech, Inc. Common Stock (PBTH) in Q3 2013, closing a stake of 50,000 shares — an estimated $315K sold.

CR Intrinsic Investors first reported a position in PBTH in Q2 2013 and held it in 1 quarter. The position peaked at $315K in Q2 2013. 3 funds tracked by Wall St. Rank hold PBTH as of Q3 2013.

CR Intrinsic Investors reported no remaining PROLOR Biotech, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
CR Intrinsic Investors sold 50,000 PROLOR Biotech, Inc. Common Stock shares in Q3 2013, an estimated $315K.
CR Intrinsic Investors first reported a position in PROLOR Biotech, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
CR Intrinsic Investors's PROLOR Biotech, Inc. Common Stock position peaked at $315K in Q2 2013.
3 funds tracked by Wall St. Rank held PROLOR Biotech, Inc. Common Stock as of Q3 2013.

Based on CR Intrinsic Investors's 13F filing for Q3 2013, filed 14 Nov 2013.